Please Wait.....
Report
Clinical Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service, Proteomics Service), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others), By Application (Translational Research v/s Clinical Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others), By company and By Region
Market Report I 2023-06-01 I 112 Pages I TechSci Research
The global clinical biomarkers market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing occurrences of infectious diseases and various types of cancer, and extensive development in technology is propelling the growth of the market. Clinical biomarkers are widely preferred in the field of clinical medicine to provide personalized treatment choices to patients. Biomarkers are essential to the rational development of medical therapeutics and are engaged in their use in in-vitro diagnostics purposes, especially in the fields of chronic disease and nutrition. The other factors supporting the market's growth are, rise in R&D activities, increasing demand for personalized treatment, increasing favorable government funding, the rising healthcare burden, rise in the aging population base, increasing demand for clinical biomarker products, a growing number of mergers and strategic acquisitions, and rise in the number of patients.
Increasing Prevalence of Infectious Diseases and Various Types of Cancer
The increasing occurrence of infectious diseases and various types of cancer across the globe is bolstering the growth of the market. A large number of people are suffering from various infectious diseases and cancers, due to which there is a surge in demand for clinical biomarkers products, which is facilitating the growth of the market. The utilization of clinical biomarkers helps to diagnose and monitor the disease and also helps to identify the patient at risk for a serious adverse event or to benefit from drug treatment. According to the Centers for Disease Control and Prevention (CDC), in 2018, 1.7 billion people were infected by TB bacteria, which is approximately 23% of the world's population. TB is the leading infectious disease in the world, taking 1.5 million lives every year. Similarly, in 2021, about 235,760 lung cancer cases were registered in the U.S. Additionally, in the U.S., over 130,000 people die every year due to lung cancer.
Technological Advancements and Rise in R&D Activities
In recent years, the adoption of highly advanced technology has allowed biomarkers to couple with novel drugs for successful diagnosis and effective treatment alternatives. For instance, in 2018, Abcam Plc., a global life sciences company, launched its product FirePlex HT Immunoassay for the quick detection of neurological biomarkers. Moreover, the rise in research and development for improving the effectiveness of clinical biomarkers is augmenting the growth of the market. For instance, in 2022, a University of Oxford study published in the Clinical Cancer Research Journal described a new type of blood test that can be utilized to detect a range of cancers and their spread in the human body. The study was done on 300 patients with non-specific but concerning symptoms of cancer, such as weight loss and fatigue. As per the study, cancer was properly detected in 19 out of every 20 patients that used the test. Metastatic disease was identified with an accuracy of 94%.
Market Segmentation
The global clinical biomarkers market is segmented into products, services, technology, clinical area, application, end user, and company. Based on the product, the market is divided into efficacy biomarkers, safety biomarkers, and validation biomarkers. Based on services, the market is divided into genomic biomarker services, tissue biomarker services, cell service, and proteomics services. Based on technology, the market is divided into next-generation sequencing, polymerase chain reaction, immunohistochemistry, enzyme-linked immunosorbent assay, and others. Based on clinical area, the market is divided into cancer biomarkers, cardiac biomarker, neurological biomarkers, infectious disease biomarkers, and others. Based on application, the market is divided into translational research and clinical diagnostics. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, diagnostic centers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rise in the adoption rate of novel technology in the country.
Market Players
Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche AG, QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., NeoGenomics Laboratories, Inc., Charles River Laboratories International, Inc., Quest Diagnostics, Inc., Abbott Laboratories, Inc., Enzo Biochem Inc., Myriad Genetics, Inc., CENTOGENE N.V., and bioMerieux S.A. are some of the leading companies operating in the market.
Report Scope:
In this report, global clinical biomarkers market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Clinical Biomarkers Market, By Product:
o Efficacy Biomarkers
o Safety Biomarkers
o Validation Biomarkers
- Clinical Biomarkers Market, By Services: -
o Genomic Biomarker Service
o Tissue Biomarker Service
o Cell Service,
o Proteomics Service
- Clinical Biomarkers Market, By Technology:
o Next-Generation Sequencing
o Polymerase Chain Reaction, Immunohistochemistry
o Enzyme-Linked Immunosorbent Assay
o Others
- Clinical Biomarkers Market, By Clinical Area: -
o Cancer Biomarker
o Cardiac Biomarker
o Neurological Biomarker
o Infectious Disease Biomarker
o Others
- Clinical Biomarkers Market, By Application:
o Translational Research
o Clinical Diagnostics
- Clinical Biomarkers Market, By End User: -
o Biotechnology & Pharmaceutical Companies
o Diagnostic Centers
o Academic & Research Institutions
o Others
- Clinical Biomarkers Market, By Region:
o North America
- United States
- Canada
- Mexico
o Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
o Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Clinical Biomarkers Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Clinical Biomarkers Market
5. Voice of Customer
6. Global Clinical Biomarkers Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers)
6.2.2. By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service,
Proteomics Service)
6.2.3. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others)
6.2.4. By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others)
6.2.5. By Application (Translational Research v/s Clinical Diagnostics)
6.2.6. By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others)
6.2.7. By Region
6.2.8. By Company (2021)
6.3. Market Map
7. North America Clinical Biomarkers Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Services
7.2.3. By Technology
7.2.4. By Clinical Area
7.2.5. By Application
7.2.6. By End User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Clinical Biomarkers Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Services
7.3.1.2.3. By Technology
7.3.1.2.4. By Clinical Area
7.3.1.2.5. By Application
7.3.1.2.6. By End User
7.3.2. Canada Clinical Biomarkers Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Services
7.3.2.2.3. By Technology
7.3.2.2.4. By Clinical Area
7.3.2.2.5. By Application
7.3.2.2.6. By End User
7.3.3. Mexico Clinical Biomarkers Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Services
7.3.3.2.3. By Technology
7.3.3.2.4. By Clinical Area
7.3.3.2.5. By Application
7.3.3.2.6. By End User
8. Europe Clinical Biomarkers Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Services
8.2.3. By Technology
8.2.4. By Clinical Area
8.2.5. By Application
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. France Clinical Biomarkers Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Services
8.3.1.2.3. By Technology
8.3.1.2.4. By Clinical Area
8.3.1.2.5. By Application
8.3.1.2.6. By End User
8.3.2. Germany Clinical Biomarkers Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Services
8.3.2.2.3. By Technology
8.3.2.2.4. By Clinical Area
8.3.2.2.5. By Application
8.3.2.2.6. By End User
8.3.3. United Kingdom Clinical Biomarkers Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Services
8.3.3.2.3. By Technology
8.3.3.2.4. By Clinical Area
8.3.3.2.5. By Application
8.3.3.2.6. By End User
8.3.4. Italy Clinical Biomarkers Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Services
8.3.4.2.3. By Technology
8.3.4.2.4. By Clinical Area
8.3.4.2.5. By Application
8.3.4.2.6. By End User
8.3.5. Spain Clinical Biomarkers Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Services
8.3.5.2.3. By Technology
8.3.5.2.4. By Clinical Area
8.3.5.2.5. By Application
8.3.5.2.6. By End User
9. Asia-Pacific Clinical Biomarkers Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Services
9.2.3. By Technology
9.2.4. By Clinical Area
9.2.5. By Application
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Clinical Biomarkers Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Services
9.3.1.2.3. By Technology
9.3.1.2.4. By Clinical Area
9.3.1.2.5. By Application
9.3.1.2.6. By End User
9.3.2. India Clinical Biomarkers Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Services
9.3.2.2.3. By Technology
9.3.2.2.4. By Clinical Area
9.3.2.2.5. By Application
9.3.2.2.6. By End User
9.3.3. Japan Clinical Biomarkers Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Services
9.3.3.2.3. By Technology
9.3.3.2.4. By Clinical Area
9.3.3.2.5. By Application
9.3.3.2.6. By End User
9.3.4. South Korea Clinical Biomarkers Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Services
9.3.4.2.3. By Technology
9.3.4.2.4. By Clinical Area
9.3.4.2.5. By Application
9.3.4.2.6. By End User
9.3.5. Australia Clinical Biomarkers Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Services
9.3.5.2.3. By Technology
9.3.5.2.4. By Clinical Area
9.3.5.2.5. By Application
9.3.5.2.6. By End User
10. South America Clinical Biomarkers Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Services
10.2.3. By Technology
10.2.4. By Clinical Area
10.2.5. By Application
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Clinical Biomarkers Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Services
10.3.1.2.3. By Technology
10.3.1.2.4. By Clinical Area
10.3.1.2.5. By Application
10.3.1.2.6. By End User
10.3.2. Argentina Clinical Biomarkers Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Services
10.3.2.2.3. By Technology
10.3.2.2.4. By Clinical Area
10.3.2.2.5. By Application
10.3.2.2.6. By End User
10.3.3. Colombia Clinical Biomarkers Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Services
10.3.3.2.3. By Technology
10.3.3.2.4. By Clinical Area
10.3.3.2.5. By Application
10.3.3.2.6. By End User
11. Middle East and Africa Clinical Biomarkers Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Services
11.2.3. By Technology
11.2.4. By Clinical Area
11.2.5. By Application
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Clinical Biomarkers Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Services
11.3.1.2.3. By Technology
11.3.1.2.4. By Clinical Area
11.3.1.2.5. By Application
11.3.1.2.6. By End User
11.3.2. Saudi Arabia Clinical Biomarkers Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Services
11.3.2.2.3. By Technology
11.3.2.2.4. By Clinical Area
11.3.2.2.5. By Application
11.3.2.2.6. By End User
11.3.3. UAE Clinical Biomarkers Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Services
11.3.3.2.3. By Technology
11.3.3.2.4. By Clinical Area
11.3.3.2.5. By Application
11.3.3.2.6. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape (Inclusive of SWOT Analysis)
14.1. Agilent Technologies, Inc.
14.2. Illumina, Inc.
14.3. F. Hoffmann-La Roche AG
14.4. QIAGEN NV
14.5. PerkinElmer, Inc
14.6. Thermo Fischer Scientific, Inc.
14.7. Bio-Rad Laboratories, Inc.
14.8. NeoGenomics Laboratories, Inc.
14.9. Charles River Laboratories International, Inc.
14.10. Quest Diagnostics, Inc.
14.11. Abbott Laboratories, Inc.
14.12. Enzo Biochem Inc.
14.13. Myriad Genetics, Inc.
14.14. CENTOGENE N.V.
14.15. bioMerieux S.A.
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security